Fexapotide TFA
Product Specifications
Target
Apoptosis
Related Pathways
Apoptosis
Bioactivity
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) .
Molecular Formula
C90H163N27O25S.xC2HF3O2
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1030150-01 0.02 mg (E-Coli)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details MBS1030150-02 0.1 mg (E-Coli)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details 
MBS1030150-03 0.02 mg (Yeast)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details MBS1030150-04 0.1 mg (Yeast)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details MBS1030150-05 0.02 mg (Baculovirus)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details MBS1030150-06 0.02 mg (Mammalian-Cell)
Recombinant Glycine max Auxin-induced protein AUX28 (AUX28)
Ask
View Details